350 related articles for article (PubMed ID: 35354729)
41. Guillain-Barré syndrome diagnosed as central cervical spinal cord injury after hyperextension injury.
Miyamoto K; Katsuki S; Yamaga H; Nakamura M; Suzuki K; Inoue G; Yagi M; Sasaki J; Dohi K; Hayashi M
Am J Emerg Med; 2022 May; 55():224.e5-224.e7. PubMed ID: 34955312
[TBL] [Abstract][Full Text] [Related]
42. Post COVID-19 Guillain-Barre syndrome presents as sensory dominant neuropathy with reversible conduction failure.
AlTahan AM; AlAnazi MH; AlTahan FA; AlAbandi FA
Neurosciences (Riyadh); 2023 Jan; 28(1):57-61. PubMed ID: 36617454
[TBL] [Abstract][Full Text] [Related]
43. [Isolated facial diplegia as an atypical variant of Guillain-Barre syndrome after suspected SARS-CoV-2 infection].
Lavilla Olleros C; López-Rubio M; Fanciulli C; González-Munera A; Millán Núñez-Cortés J
Rev Fac Cien Med Univ Nac Cordoba; 2021 Dec; 78(4):405-407. PubMed ID: 34962738
[TBL] [Abstract][Full Text] [Related]
44. COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy.
Garnero M; Del Sette M; Assini A; Beronio A; Capello E; Cabona C; Reni L; Serrati C; Bandini F; Granata A; Pesce G; Mancardi GL; Uccelli A; Schenone A; Benedetti L
J Neurol Sci; 2020 Nov; 418():117114. PubMed ID: 32947089
[TBL] [Abstract][Full Text] [Related]
45. Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination.
Ogata S; Ishii Y; Asano K; Kobayashi E; Kubota S; Takahashi K; Miyaji Y; Higashiyama Y; Joki H; Doi H; Koga M; Takeuchi H; Tanaka F
Intern Med; 2022 Jun; 61(11):1757-1760. PubMed ID: 35342134
[TBL] [Abstract][Full Text] [Related]
46. Concomitant Guillain-Barre syndrome with COVID-19: a case report.
Mackenzie N; Lopez-Coronel E; Dau A; Maloof D; Mattar S; Garcia JT; Fontecha B; Lanata CM; Guillen-Burgos HF
BMC Neurol; 2021 Mar; 21(1):135. PubMed ID: 33757457
[TBL] [Abstract][Full Text] [Related]
47. Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection in a Pediatric Patient.
Frank CHM; Almeida TVR; Marques EA; de Sousa Monteiro Q; Feitoza PVS; Borba MGS; Vasconcelos HL; de Souza Bastos M; Lacerda MVG
J Trop Pediatr; 2021 Jul; 67(3):. PubMed ID: 32653906
[TBL] [Abstract][Full Text] [Related]
48. The challenge of diagnosing Guillain-Barre syndrome in patients with COVID-19 in the intensive care unit.
Diaz P; Leveque M; Hautecloque G; Sellal F; Augereau O; Lita L; Biegle E; Belilita L; Bouterra C; Rerat P; Alvarez-Gonzalez A; Martinot M; Gerber V
J Neuroimmunol; 2022 May; 366():577842. PubMed ID: 35339941
[TBL] [Abstract][Full Text] [Related]
49. Guillain-Barré syndrome associated with COVID-19 infection: a case from the UK.
Tiet MY; AlShaikh N
BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32641309
[TBL] [Abstract][Full Text] [Related]
50. Concurrence of Guillain-Barré syndrome and primary biliary cholangitis not related to SARS-CoV-2: Case report.
Segura-Chávez D; Tagle-Lostaunau I; Sifuentes-Monge J; Aquino-Peña F
Medwave; 2023 Apr; 23(3):. PubMed ID: 37115660
[TBL] [Abstract][Full Text] [Related]
51. To be, or not to be… Guillain-Barré Syndrome.
Florian IA; Lupan I; Sur L; Samasca G; Timiș TL
Autoimmun Rev; 2021 Dec; 20(12):102983. PubMed ID: 34718164
[TBL] [Abstract][Full Text] [Related]
52. [Finger drop variant of Guillain-Barré syndrome: a case report].
Fujii Y; Kanbayashi T; Kobayashi S; Uchibori A; Chiba A; Sonoo M
Rinsho Shinkeigaku; 2022 Oct; 62(10):810-813. PubMed ID: 36184417
[TBL] [Abstract][Full Text] [Related]
53. Guillain-Barré Syndrome and multiple lacunar infarcts in a COVID-19 patient.
Suci YD; Rosyid AN; Wulaa NL; Alamsyah M; Irmayani Ak ; Bachrun T
J Infect Dev Ctries; 2023 Nov; 17(11):1641-1646. PubMed ID: 38064394
[TBL] [Abstract][Full Text] [Related]
54. Guillain-Barré syndrome following thoracic spinal cord trauma.
Scozzafava J; Jickling G; Jhamandas JH; Jacka MJ
Can J Anaesth; 2008 Jul; 55(7):441-6. PubMed ID: 18591702
[TBL] [Abstract][Full Text] [Related]
55. Cranial Nerve Involvement and Dysautonomia in Post-COVID-19 Guillain-Barré Syndrome.
Kakumoto T; Kobayashi S; Yuuki H; Kainaga M; Shirota Y; Hamada M; Hashimoto Maeda M; Kubota A; Kawai M; Saito M; Ishiura H; Toda T
Intern Med; 2021 Nov; 60(21):3477-3480. PubMed ID: 34433712
[TBL] [Abstract][Full Text] [Related]
56. Relation between Guillain-Barré syndrome and Covid-19: Case-Series.
Jumagaliyeva MB; Ayaganov DN; Abdelazim IA; Saparbayev SS; Tuychibaeva NM; Kurmambayev YJ
J Med Life; 2023 Sep; 16(9):1433-1435. PubMed ID: 38107719
[TBL] [Abstract][Full Text] [Related]
57. Post-COVID-19 bifacial weakness and paraesthesia: a case report.
Stuby J; Roth R; Strecker N; Teubner J; Rudiger A
Swiss Med Wkly; 2021 Sep; 151():w30066. PubMed ID: 34569221
[TBL] [Abstract][Full Text] [Related]
58. SARS-CoV-2 and Guillain-Barré Syndrome: Lessons from Viral Infections.
Meidaninikjeh S; Sabouni N; Taheri M; Borjkhani M; Bengar S; Majidi Zolbanin N; Khalili A; Jafari R
Viral Immunol; 2022 Jul; 35(6):404-417. PubMed ID: 35766944
[TBL] [Abstract][Full Text] [Related]
59. [The first Hungarian patient with Guillain-Barre syndrome after COVID-19].
Al-Muhanna N; Béres-Molnár AK; Jarecsny T; Folyovich A
Ideggyogy Sz; 2021 Jan; 74(1-2):64-66. PubMed ID: 33497053
[TBL] [Abstract][Full Text] [Related]
60. [A case of pure-sensory-type Guillain-Barré syndrome with galactocerebroside antibody].
Kogawa S; Nakajima A; Kobashi S; Samukawa M; Kusunoki S
Rinsho Shinkeigaku; 2015; 55(3):171-3. PubMed ID: 25786754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
